posted
jdizz - what in particular were you referring to by the way? I don't think I've EVER pumped anything in the 6 years I've posted here. Like I said above - I may get excited at times - but I've learned over the years that these pennies will break your heart more times than not...
IP: Logged |
posted
ok finaly you answere me lol ive been trying to have you answere a single question for months... thats why i asked if you were pumping b.c pumpers dont care what anyone else has to say.. alot of people on this board have tried to ask you anseres with no response. honestly you make everything interesting on this board.. whenever i asked u a question on nxhd you just disapeard and quit posting there.. i wasn't trying to be rude.. keep up the good work, you seem really educated on your dd..
-------------------- dont make yourself loose money in a stock that you had a resonable profit in
IP: Logged |
posted
When did you ask me a question? Under which thread? I'm sorry. Sometimes I don't log on for days or weeks at a time... In fact - there was a period of time I was almost totally out of the market, about 2-4 years ago - for almost 2 years! When Real Estate was HOT here in So. FL. (The only thing hot here now is going outside - RE in the toilet - HUGE unemployment, and property taxes and hurricane insurance premiums that will choke 2 cows)! Also - I'm not very smart when it comes to stocks. For me - this is like going to the HArd Rock and playing blackjack! (Although sometimes I get to hang onto my money a little longer here)!
Good Luck - Please re-write your questions and I'll answer the best I can.
posted
NEWS: GEN VEC gets Grant worth $600,000 awarded!
GenVec Receives Grant for Malaria Vaccine ProgramLast update: 7/29/2009 8:00:00 AMGAITHERSBURG, Md., July 29, 2009 /PRNewswire-FirstCall via COMTEX/ -- GenVec, Inc. (GNVC) announced today that it has received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the company's malaria vaccine program. "We appreciate the support this grant offers GenVec. This funding supports the advancement of GenVec technology by moving GenVec into the antigen discovery phase of vaccine development," said Dr. Joseph Bruder, head of GenVec's malaria program. This grant, valued at approximately $600,000 over two years, will be used to identify new immunogenic antigens for malaria vaccine development. Using the funding from this grant, GenVec will be collaborating with the U.S. Naval Medical Research Center (NMRC) to apply its adenovector technology to the development of malaria vaccine candidates. About GenVec GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. Additional information about GenVec is available at and in the company's various filings with the Securities and Exchange Commission. SOURCE GenVec, Inc. Copyright (C) 2009 PR Newswire. All rights reserved
IP: Logged |
posted
jdizz - I don't remember ever being in NXHD. Also - I just looked at my account - I only did 2 trades from Jan. 30 - May 30. Sold PYTO and bought more NXG.
Like I said, when I'm really busy with Real Estate I don't come on these boards much.
I see yyou're from Houston! One of the smarter ones here - Invester - is also from Houston.
And believe me - nobody is always right - or they'd be rich!
posted
jdiddy - CONGRATS! smartee !! I guess Houston wins on this board! :-)
I can't believe how promising this looked this morning on the news. I thought it would be such a good day that I raised my sell from $1 to $1.10! Oh well - sooner or later....
IP: Logged |
posted
GenVec Announces Second Quarter 2009 Results Conference Call
Last update: 7/30/2009 8:35:00 AMGAITHERSBURG, Md., July 30, 2009 /PRNewswire-FirstCall via COMTEX/ -- GenVec, Inc. (GNVC) announced that it will release financial results for the second quarter ended June 30, 2009 on Thursday, August 6, 2009 after market close. GenVec will hold a conference call at 10:00 a.m. EDT on Friday, August 7, 2009 to discuss the company's second quarter results. To listen to the live conference call, please dial 888-679-8033 (U.S. or Canada) or 617-213-4846 (international) and use access code 57544597. Participants may pre-register for the call anytime at: https://. Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference. An audio replay of the conference call will be available starting at 1:00 p.m. on August 7, 2009 through August 14, 2009. To listen to the audio replay, dial 888-286-8010 (U.S. or Canada) or 617-801-6888 (international) and use access code 93256887. A live webcast of the conference call will be available on the Company's website and will be archived for 30 days. To access the webcast or the replay, go to , click on "Investor Relations," and click on "Webcasts and Data." About GenVec GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. Additional information about GenVec is available at and in the company's various filings with the Securities and Exchange Commission. SOURCE GenVec, Inc. Copyright (C) 2009 PR Newswire. All rights reserved
IP: Logged |
posted
Hey dizz...i think you might of had the wrong love....it's the other "LUV" (luvthemoney or luvthatmoney) that doesn't respond to people!!! That's funny. This "love" (love the market) is a GOOD GUY, not a pumper and doesn't vanish when asked a question. Cheers :-)
IP: Logged |
If this goes down to .75 tomorrow morning I think I'll buy some more - I sold my HBAN today for a nice .25/share profit after a scare yesterday!
The only steady money I've made this year has been with NXG and HBAN - big board stuff. I've killed myself on the pennies by not selling when I should......and trying to "WISH" a few of my losers to do a Lazarus!
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Were Up]](graemlins/wereup.gif)
